transduced cells were split and 2.2 x 10 4 cells/well were seed on Mitomycin C treated MEF feeder layer in 12-well tissue culture plates. Cells were maintained in ES complete media (DMEM with 4.5 g/L D-glucose supplemented with 15% heat-inactivated fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 0.25 μg/mL fungizone, 100 μM β-mercaptoethanol and 1000 U/mL leukemia inhibitory factor (Chemicon)) and treated with vehicle 
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Actin-AcGFP-LID. Human -actin fused to AcGFP (Aequorea Victoria) and mCherry (Clontech)
were cloned in pBMN vector with iBlasticidin and iPuromycin, respectively. A 6-amino acid linker (GlyGlySerGlyGlySer) was introduced in between -actin and the fluorescent proteins. The LID domain was fused to the C-terminus of AcGFP. NIH3T3 cells were double transduced with Actin-AcGFP-LID and Actin-mCherry followed by drug selection (DMEM supplemented with 10% heat-inactivated donor bovine serum, 2 mM glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin growth media supplemented with 5 g/mL blasticidin or 5 g/mL puromycin) for one week. Stably transduced cells were plated on 2-well chamber slides and treated with vehicle or with 2 M Shield-1 for 24 hours. Cells were then treated with 1 g/mL Hoechst 33342
for 5 minutes, fixed using 3.7% formaldehyde and imaged with a 40x objective on Zeiss Axioskop 2 epifluorescence microscope. In the presence of Shield-1, the spectra of FKBP(F36V) gave strong resonance peaks and could be easily assigned. 
